APA (7th ed.) Citation

Xu, L., Zhou, Y., Ma, R., Guo, X., Chen, H., Fan, L., & Wang, X. (2024). The andrographolide derivative, AND7, and TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation. Compuscript Ltd.

Chicago Style (17th ed.) Citation

Xu, Letian, Yuting Zhou, Rui Ma, Xinqin Guo, Hao Chen, Lei Fan, and Xiaoming Wang. The Andrographolide Derivative, AND7, and TRAIL Combination Attenuates Acute Lymphoblastic Leukemia Through P53-regulated ROS Accumulation. Compuscript Ltd, 2024.

MLA (9th ed.) Citation

Xu, Letian, et al. The Andrographolide Derivative, AND7, and TRAIL Combination Attenuates Acute Lymphoblastic Leukemia Through P53-regulated ROS Accumulation. Compuscript Ltd, 2024.